tiprankstipranks
Trending News
More News >
New Japan Chemical Co., Ltd. (JP:4406)
:4406
Japanese Market

New Japan Chemical Co., Ltd. (4406) AI Stock Analysis

Compare
0 Followers

Top Page

JP

New Japan Chemical Co., Ltd.

(4406)

Rating:60Neutral
Price Target:
¥195.00
▼(-4.41%Downside)
New Japan Chemical Co., Ltd. receives a moderate overall stock score of 60. The financial performance is stable, but cash flow concerns weigh heavily on the outlook. Technical analysis provides no clear direction, and while valuation is reasonable, it doesn't indicate significant upside. The absence of notable earnings call insights or corporate events leaves the focus on financial and technical factors.

New Japan Chemical Co., Ltd. (4406) vs. iShares MSCI Japan ETF (EWJ)

New Japan Chemical Co., Ltd. Business Overview & Revenue Model

Company DescriptionNew Japan Chemical Co., Ltd. (4406) is a Japanese company specializing in the production and sale of chemical products. The company operates in various sectors, including the manufacturing of basic chemicals, specialty chemicals, and advanced materials. Its core products include high-performance chemicals, resins, and additives used across industries such as automotive, electronics, and pharmaceuticals.
How the Company Makes MoneyNew Japan Chemical Co., Ltd. generates revenue primarily through the manufacturing and sale of its chemical products. The company's key revenue streams include sales of specialty chemicals, resins, and additives to industrial clients in sectors like automotive, electronics, and pharmaceuticals. Additionally, the company may engage in strategic partnerships and collaborations with other firms to enhance its product offerings and expand its market reach, contributing to its earnings. The company's focus on innovation and quality assurance enables it to maintain long-term relationships with its clients, ensuring a steady flow of income.

New Japan Chemical Co., Ltd. Financial Statement Overview

Summary
New Japan Chemical Co., Ltd. shows moderate financial health with stable profitability and manageable leverage. However, there are concerns regarding cash flow stability and revenue growth. The positive trends in operational efficiency are encouraging, but liquidity concerns need to be addressed to ensure long-term sustainability.
Income Statement
65
Positive
The company shows moderate profitability with a gross profit margin of around 16-17% in recent years. However, the net profit margin remains low, indicating significant expenses or inefficiencies. There is a slight decline in revenue over the past few years, but the EBIT and EBITDA margins have improved recently, reflecting better operational efficiency.
Balance Sheet
70
Positive
The balance sheet is relatively stable with a debt-to-equity ratio of approximately 0.4, suggesting manageable leverage. The equity ratio is strong, indicating a solid financial structure. However, there's been a slight decline in total assets and equity over the last few years, which might limit future growth.
Cash Flow
50
Neutral
Cash flow performance is mixed with significant fluctuations. The operating cash flow to net income ratio has been volatile, and free cash flow has been negative in recent years, indicating potential liquidity issues. The inconsistency in free cash flow growth further adds to the concerns.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue33.48B32.70B32.86B33.10B32.36B24.44B
Gross Profit5.86B5.45B5.32B4.42B5.88B4.56B
EBITDA1.82B1.56B1.31B532.00M1.78B1.35B
Net Income987.00M522.00M220.00M-444.00M811.00M501.00M
Balance Sheet
Total Assets40.56B37.52B40.11B38.55B40.09B35.89B
Cash, Cash Equivalents and Short-Term Investments3.52B2.94B3.82B2.96B3.50B3.15B
Total Debt7.93B7.13B7.58B10.16B9.96B8.91B
Total Liabilities21.08B18.52B21.64B21.60B23.09B19.67B
Stockholders Equity18.27B17.79B17.29B15.86B15.94B15.21B
Cash Flow
Free Cash Flow0.00-889.00M2.80B-593.00M-705.00M-680.00M
Operating Cash Flow0.00-224.00M3.58B104.00M1.08B1.25B
Investing Cash Flow0.00-174.00M-60.00M-659.00M-1.60B-1.71B
Financing Cash Flow0.00-513.00M-2.60B-3.00M861.00M519.00M

New Japan Chemical Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price204.00
Price Trends
50DMA
191.84
Positive
100DMA
193.35
Positive
200DMA
193.06
Positive
Market Momentum
MACD
4.39
Negative
RSI
59.82
Neutral
STOCH
61.95
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4406, the sentiment is Positive. The current price of 204 is above the 20-day moving average (MA) of 194.75, above the 50-day MA of 191.84, and above the 200-day MA of 193.06, indicating a bullish trend. The MACD of 4.39 indicates Negative momentum. The RSI at 59.82 is Neutral, neither overbought nor oversold. The STOCH value of 61.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4406.

New Japan Chemical Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (70)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥6.86B11.75
2.67%6.93%-6.22%
75
Outperform
¥17.88B6.99
4.53%0.79%60.97%
74
Outperform
¥17.38B11.07
2.45%5.96%182.60%
71
Outperform
¥23.94B7.25
3.07%9.75%28.00%
70
Outperform
¥175.99B11.226.29%3.46%3.94%5.74%
66
Neutral
¥8.14B5.26
1.51%11.14%148.17%
60
Neutral
¥7.61B15.07
1.47%-0.49%137.27%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4406
New Japan Chemical Co., Ltd.
211.00
1.15
0.55%
JP:4092
Nippon Chemical Industrial Co., Ltd.
2,023.00
-708.60
-25.94%
JP:4112
Hodogaya Chemical Co., Ltd.
1,450.00
-1,192.90
-45.14%
JP:4409
Toho Chemical Industry Company, Limited
812.00
284.45
53.92%
JP:4629
Daishin Chemical Co., Ltd.
1,500.00
42.11
2.89%
JP:4957
Yasuhara Chemical Co., Ltd.
793.00
38.89
5.16%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025